The Efficacy of Imipenem Conjugated with Synthesized Silver Nanoparticles Against Acinetobacter baumannii Clinical Isolates, Iran

被引：0
|
作者：
Elham Zendegani
Samaneh Dolatabadi
机构：
[1] Islamic Azad University,Department of Microbiology, Faculty of Sciences, Neyshabur Branch
来源：
Biological Trace Element Research | 2020年 / 197卷
关键词：
Nosocomial infection; Imipenem; β-lactamases; Silver nanoparticles; Iran;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Carbapenem-resistant Acinetobacter baumannii (CRAB) remains as a serious cause of infectious diseases and septic mortality in hospitalized patients worldwide. This study was conducted to evaluate the antimicrobial effect of imipenem conjugated silver nanoparticles (AgNPs) on resistant isolated A. baumannii from nosocomial infections.
引用
收藏
页码：330 / 340
页数：10
相关论文
共 50 条
  • [41] In vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia
    Insa, R.
    Cercenado, E.
    Goyanes, M. J.
    Morente, A.
    Bouza, E.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (03) : 583 - 585
  • [42] Antimicrobial susceptibility of clinical isolates of Acinetobacter baumannii
    Shi, ZY
    Liu, PYF
    Lau, YJ
    Lin, YH
    Hu, BS
    Shir, JM
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1996, 24 (02) : 81 - 85
  • [43] Triclosan resistance in clinical isolates of Acinetobacter baumannii
    Chen, Yagang
    Pi, Borui
    Zhou, Hua
    Yu, Yunsong
    Li, Lanjuan
    JOURNAL OF MEDICAL MICROBIOLOGY, 2009, 58 (08) : 1086 - 1091
  • [44] Antibacterial activity of modified natural clinoptilolite against clinical isolates of Acinetobacter baumannii
    Hrenovic, Jasna
    Milenkovic, Jelena
    Goic-Barisic, Ivana
    Rajic, Nevenka
    MICROPOROUS AND MESOPOROUS MATERIALS, 2013, 169 : 148 - 152
  • [45] Minocycline activity against clinical isolates of multidrug-resistant Acinetobacter baumannii
    Adibhesami, H.
    Douraghi, M.
    Rahbar, M.
    Abdollahi, A.
    CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (11) : E79 - E80
  • [46] In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan
    Liu, Jien-Wei
    Wang, Lih-Shinn
    Cheng, Yu-Jen
    Hsu, Gwo-Jong
    Lu, Po-Liang
    Liu, Yung-Ching
    Chen, Chih-Ming
    Lee, Chun-Ming
    Sun, Wu
    Jang, Tsrang-Neng
    Chiang, Ping-Cherng
    Chuang, Yin-Ching
    Lin, Hsiu-Chen
    Shi, Zhi-Yuan
    Kung, Hsiang-Chi
    Huang, Cheng-Hua
    Tsao, Shih-Ming
    Lu, Chin-Te
    Liao, Chun-Hsing
    Hsueh, Po-Ren
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 32 : S188 - S191
  • [47] Persister formation in Acinetobacter baumannii clinical isolates
    Baek, M. S.
    Chung, E. S.
    Ko, K. S.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S158 - S158
  • [48] In vitro synergy test of meropenem and sulbactam against clinical isolates of Acinetobacter baumannii
    Kiffer, CRV
    Sampaio, JLM
    Sinto, S
    Oplustil, CP
    Koga, PCM
    Arruda, AC
    Turner, PJ
    Mendes, C
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 52 (04) : 317 - 322
  • [49] Colistin/imipenem/cilastatinLack of efficacy in Acinetobacter baumannii septicaemia: case report
    Reactions Weekly, 2011, 1351 (1) : 18 - 18
  • [50] Synergic in-vitro activity of imipenem and sulbactam against Acinetobacter baumannii
    Choi, JY
    Park, YS
    Cho, CH
    Park, YS
    Shin, SY
    Song, YG
    Yong, D
    Lee, K
    Kim, JM
    CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (12) : 1098 - 1101
12345